Cargando…
Tyrosine triple mutated AAV2-BDNF gene therapy in an inner retinal injury model induced by intravitreal injection of N–methyl-D-aspartate (NMDA)
PURPOSE: Glaucoma is a group of chronic optic neuropathies characterized by the degeneration of retinal ganglion cells (RGCs) and their axons, and they ultimately cause blindness. Because neuroprotection using neurotrophic factors against RGC loss has been proven a beneficial strategy, extensive att...
Autores principales: | Shiozawa, Asaka Lee, Igarashi, Tsutomu, Kobayashi, Maika, Nakamoto, Kenji, Kameya, Shuhei, Fujishita, Shigeto, Takahashi, Hiroshi, Okada, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7300199/ https://www.ncbi.nlm.nih.gov/pubmed/32565669 |
Ejemplares similares
-
Tyrosine triple mutated AAV2-BDNF gene therapy in a rat model of transient IOP elevation
por: Igarashi, Tsutomu, et al.
Publicado: (2016) -
Drinking hydrogen water improves photoreceptor structure and function in retinal degeneration 6 mice
por: Igarashi, Tsutomu, et al.
Publicado: (2022) -
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
por: Mowat, FM, et al.
Publicado: (2013) -
Differential Effects of AAV.BDNF and AAV.Ntf3 in the Deafened Adult Guinea Pig Ear
por: Budenz, Cameron L., et al.
Publicado: (2015) -
Optical Coherence Tomography Angiography of Nonarteritic Cilioretinal Artery Occlusion Alone
por: Ikebukuro, Toyo, et al.
Publicado: (2021)